TD Cowen Has Lowered Expectations for P3 Health Partners (NASDAQ:PIII) Stock Price

P3 Health Partners (NASDAQ:PIII) had its target price decreased by research analysts at TD Cowen from $13.00 to $4.00 in a note issued to investors on Wednesday, Benzinga reports. The firm currently has a “hold” rating on the stock. TD Cowen‘s price objective would suggest a potential upside of 21.03% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the company. Lake Street Capital reiterated a “buy” rating and set a $23.00 price target on shares of P3 Health Partners in a report on Tuesday, August 11th. Weiss Ratings cut P3 Health Partners from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $13.67.

P3 Health Partners Stock Down 2.2%

PIII stock traded down $0.07 during mid-day trading on Wednesday, reaching $3.31. 9,185 shares of the company traded hands, compared to its average volume of 408,609. The firm’s 50 day moving average price is $5.92 and its 200 day moving average price is $6.58. The stock has a market cap of $23.99 million, a price-to-earnings ratio of -0.14 and a beta of 1.81. P3 Health Partners has a fifty-two week low of $1.52 and a fifty-two week high of $16.89.

P3 Health Partners (NASDAQ:PIII) last issued its quarterly earnings data on Monday, November 9th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($3.96) by $4.03. The company had revenue of $396.34 million during the quarter, compared to analysts’ expectations of $384.95 million.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in P3 Health Partners stock. Diversified Trust Co raised its holdings in P3 Health Partners Inc. (NASDAQ:PIII) by 73.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,289 shares of the company’s stock after purchasing an additional 9,849 shares during the quarter. Diversified Trust Co owned 0.32% of P3 Health Partners worth $158,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 7.75% of the company’s stock.

About P3 Health Partners

P3 Health Partners Inc. is a physician-led healthcare company focused on value-based care for Medicare Advantage beneficiaries. The company works with primary care physicians, specialists, health plans and community organizations to coordinate care and improve health outcomes while addressing patients’ medical and social needs. Its services include primary care support, care coordination, chronic-condition management, preventive care, medication management and patient navigation. P3’s model uses an integrated care team and data-driven clinical programs to help physicians manage the health of senior populations across the care continuum.